Condition: Septic Shock · Sepsis · Hypovolemia · Sponsor: Vivacelle Bio
This study is being conducted to evaluate the safety and effectiveness of VBI-S in elevating the blood pressure of septic shock patients with absolute or relative hypovolemia.
This description comes directly from the study's public registry record.
Cuthbert O Simpkins, MD, FACS · 3187711294 · cuthbert@vivacellebio.com
Always discuss trial participation with your own doctor first.
| Dignity Health Chandler Regional Medical Center | Chandler, Arizona, United States | Recruiting |
| Memorial Health University Medical Center | Savannah, Georgia, United States | Recruiting |
| University Health | Kansas City, Missouri, United States | Recruiting |
| Bryan Medical Center | Lincoln, Nebraska, United States | Withdrawn |
| Novant Healthcare | Winston-Salem, North Carolina, United States | Recruiting |
| Oregon Health & Science University (OHSU) | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06072430